Status:

COMPLETED

Education Intervention in Encouraging Health Providers to Talk With Cancer Patients About the Use of Complementary and Alternative Medicine

Lead Sponsor:

M.D. Anderson Cancer Center

Collaborating Sponsors:

National Cancer Institute (NCI)

Conditions:

Unspecified Adult Solid Tumor, Protocol Specific

Unspecified Childhood Solid Tumor, Protocol Specific

Eligibility:

All Genders

Phase:

PHASE3

Brief Summary

RATIONALE: Educating health providers on talking with cancer patients about complementary and alternative medicine (CAM) may help encourage health providers to talk more often with cancer patients abo...

Detailed Description

OBJECTIVES: Primary * Examine the efficacy of an education intervention designed to increase the frequency with which health providers ask cancer patients about their use of complimentary and altern...

Eligibility Criteria

Inclusion

  • DISEASE CHARACTERISTICS:
  • Health provider meeting the following criteria:
  • Has regular contact with cancer patients by initially talking with patients, taking their histories, and conveying pertinent information to their physician at a participating CCOP site
  • Must be actively seeing patients at a participating University of Texas (UT) MD Anderson Cancer Center Community Clinical Oncology Program (CCOP) site
  • Must not be employed at more than one participating CCOP site
  • Not a temporary employee
  • Patient of a health provider at a participating CCOP site meeting the following criteria:
  • Current diagnosis of cancer including amyloidosis
  • Diagnosed at least 1 week ago
  • Finished treatment within the past 6 months
  • Able to speak or read English
  • No prior participation in this study at an earlier assessment
  • PATIENT CHARACTERISTICS:
  • Not specified
  • PRIOR CONCURRENT THERAPY:
  • Not specified

Exclusion

    Key Trial Info

    Start Date :

    June 1 2008

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 7 2020

    Estimated Enrollment :

    1356 Patients enrolled

    Trial Details

    Trial ID

    NCT00608933

    Start Date

    June 1 2008

    End Date

    December 7 2020

    Last Update

    December 9 2020

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill

    Chapel Hill, North Carolina, United States, 27599-7295

    2

    University of Texas MD Anderson Cancer Center

    Houston, Texas, United States, 77030-4009

    Education Intervention in Encouraging Health Providers to Talk With Cancer Patients About the Use of Complementary and Alternative Medicine | DecenTrialz